Seeing Is Believing
AMLX is currently covered by 5 analysts with an average price target of $9.49. This is a potential upside of $6.37 (204.17%) from yesterday's end of day stock price of $3.12.
Amylyx Pharmaceuticals's activity chart (see below) currently has 12 price targets and 36 ratings on display. The stock rating distribution of AMLX is 88% BUY and 12% HOLD.
Analysts average stock forecasts to be materialized ratio is 21.09% with an average time for these price targets to be met of 138.2 days.
Highest price target for AMLX is $8, Lowest price target is $3, average price target is $9.49.
Most recent stock forecast was given by CHRIS SHIBUTANI from GOLDMAN SACHS on 12-Jul-2024.
Currently out of the existing stock ratings of AMLX, 22 are a BUY (88%), 3 are a HOLD (12%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Hold
$4
$0.88 (28.21%)
$4
2 months 23 days ago
2/7 (28.57%)
$1.84 (85.19%)
198
Buy
$8
$4.88 (156.41%)
$8
2 months 25 days ago
4/17 (23.53%)
$5.93 (286.47%)
177
Hold
$3
$-0.12 (-3.85%)
$4
4 months 21 days ago
1/5 (20%)
$1.13 (60.43%)
129
Buy
$50
6 months 24 days ago
1/3 (33.33%)
$22.97 (84.98%)
187
What is AMLX (Amylyx Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on AMLX (Amylyx Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on AMLX (Amylyx Pharmaceuticals)?
Which analyst is the currently most bullish on AMLX (Amylyx Pharmaceuticals)?
Which analyst is the currently most reserved on AMLX (Amylyx Pharmaceuticals)?